Abstract:Introduction: Osteosarcoma is the most common primary malignant tumor in children and young patients. Although neoadjuvant chemotherapy and surgery could improve the prognosis of these patients, treatment outcomes are poor because of its low early diagnosis rate and high degree of malignancy as well as its tendency for early metastasis. In the field of osteosarcoma, lncRNAs have become a hot spot for studying the molecular mechanisms driving malignant biological characteristics and exploring effective treatment methods. An lncRNA is a long noncoding RNA lacking protein-encoding ability, and in its RNA form, it regulates various gene expression processes, such as epigenetic regulation, transcriptional regulation, and post-transcriptional regulation. LncRNAs play an important role in tumorigenesis and metastasis.Methods: We used bioinformatics software to analyze the data in geo database. CCK-8 and Transwell were used to detect the effect of lncRNA LINC00691 on the proliferation and migration of osteosarcoma cells. The target gene of LINC00691 was detected by bioinformatics analysis and RNA pull down.Results: In this study, we identified the lncRNA LINC00691 and confirmed its expression in osteosarcoma cells through GEO database analysis. Expression analysis showed that the levels of IncRNA LINC00691 in osteosarcoma cells were decreased compared to those of control cells. Overexpression of LINC00691 could inhibit the proliferation, migration, invasion, and induction of G1 cell cycle arrest in osteosarcoma cells, which was shown through in vitro and in vivo studies. Using bioinformatics analysis, RNA pull down experiments and luciferase reporter gene detection assays, we found that LINC00691 regulated ST5 expression by binding miR-1256. LINC00691 overexpression inhibited EMT by promoting the expression of E-cadherin and increasing the expression of ZEB1, Snail, and Fibronectin.Conclusion: These results suggested that overexpressed LINC00691 promoted the expression of ST5 by regulating the function of miR-1256 through a ceRNA mechanism. The LINC00691/miR-1256/ST5 pathway plays an important role in the progression and metastasis of osteosarcoma and represents a good therapeutic target.

LINC01614 promotes osteosarcoma progression via miR-520a-3p/SNX3 axis

LINC01614 Promotes Osteosarcoma Progression As Cerna to Target SNX3 by Sponging Hsa-Mir-520a-3p

Long Non-Coding RNA XIST Predicts Poor Prognosis and Promotes Malignant Phenotypes in Osteosarcoma

LncRNA SATB2-AS1 Promotes Tumor Growth and Metastasis and Affects the Tumor Immune Microenvironment in Osteosarcoma by Regulating SATB2

LINC00174 Facilitates Cell Proliferation, Cell Migration and Tumor Growth of Osteosarcoma Via Regulating the TGF-β/SMAD Signaling Pathway and Upregulating SSH2 Expression

LncRNA SNHG16 Contributes to Osteosarcoma Progression by Acting As a Cerna of Mir-1285-3p.

LINC00612 Functions As a Cerna for Mir-214–5P to Promote the Proliferation and Invasion of Osteosarcoma in Vitro and in Vivo

LINC01128 regulates the development of osteosarcoma by sponging miR‐299‐3p to mediate MMP2 expression and activating Wnt/β‐catenin signalling pathway

LINC01116 Targets Mir-520A-3p and Affects IL6R to Promote the Proliferation and Migration of Osteosarcoma Cells Through the Jak-stat Signaling Pathway.

LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR‐516b‐5p/Gli1 axis

Silencing of Long Non-Coding RNA LINC00607 Prevents Tumor Proliferation of Osteosarcoma by Acting as a Sponge of miR-607 to Downregulate E2F6

Lncrna AC007207.2 Promotes Malignant Properties of Osteosarcoma Via the Mir-1306-5p/sirt7 Axis.

LncRNA DLX6-AS1 Promotes Tumor Proliferation and Metastasis in Osteosarcoma Through Modulating Mir-641/Hoxa9 Signaling Pathway.

The lncRNA LINC00691 Functions as a ceRNA for miRNA-1256 to Suppress Osteosarcoma by Regulating the Expression of ST5

LncRNA LINC00588 Suppresses the Progression of Osteosarcoma by Acting As a Cerna for Mirna-1972.

Down-regulation of LINC00472 Promotes Osteosarcoma Tumorigenesis by Reducing FOXO1 Expressions Via Mir-300.

The Lncrna Linc0069/Functions As A Cerna For Mirna-1256 To Suppress Osteosarcoma By Regulating The Expression Of St5

LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors in vitro and tumor growth and metastasis in vivo through the PI3K/Akt signaling

Lncrna FBXL19-AS1 Regulates Osteosarcoma Cell Proliferation, Migration and Invasion by Sponging Mir-346

LncRNA LBX2-AS1 impacts osteosarcoma sensitivity to JQ-1 by sequestering miR-597-3p away from BRD4

Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.